Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...
The announcement comes a few days after Merck KGaA’s development partner Avillion announced supportive results in a phase 2 psoriasis trial. MoonLake has swiftly in-licensed the drug discovered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback